Hebei Medical University Fourth Hospital

This study is testing a new treatment approach for early-stage HER2-positive breast cancer. It combines an experimental drug called pyrotinib with standard chemotherapy drugs, all given before surgery. The goal is to see if this combination can more effectively shrink or eliminat…